Wed, March 16, 2011
Tue, March 15, 2011
Mon, March 14, 2011
[ Mon, Mar 14th 2011 ] - Market Wire
30 AM E.T.
Sun, March 13, 2011
Sat, March 12, 2011
Fri, March 11, 2011
[ Fri, Mar 11th 2011 ] - Market Wire
Covidien????????????????FDA??
Thu, March 10, 2011
Wed, March 9, 2011
Tue, March 8, 2011
Mon, March 7, 2011
Sat, March 5, 2011
Fri, March 4, 2011
Thu, March 3, 2011
Wed, March 2, 2011
[ Wed, Mar 02nd 2011 ] - Market Wire
BURCON AMENDS LETTER OF INTENT
Tue, March 1, 2011
Mon, February 28, 2011
Sun, February 27, 2011
Fri, February 25, 2011

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of TomoTh


//health-fitness.news-articles.net/content/2011/ .. es-of-fiduciary-duty-by-the-board-of-tomoth.html
Published in Health and Fitness on Monday, March 7th 2011 at 10:40 GMT by Market Wire   Print publication without navigation


NEW YORK--([ BUSINESS WIRE ])--Levi & Korsinsky is investigating the Board of Directors of TomoTherapy Incorporated (aTomoTherapya or the aCompanya) (Nasdaq: TOMO) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the company to Accuray Incorporated (aAccuraya) (Nasdaq: ARAY). Under the terms of the agreement, TomoTherapy stockholders will receive $3.15 in cash and 0.1648 shares of Accuray stock for every share of TomoTherapy common stock they own, representing a value of $4.80 per share. The transaction has a total value of approximately $277 million.

Click here to learn more about the investigation: [ http://www.zlk.com/tomotherapy-tomo.html ], or call: 877-363-5972.

The investigation concerns whether the TomoTherapy Board of Directors breached their fiduciary duties to TomoTherapy stockholders by failing to adequately shop the Company before entering into this transaction and whether Accuray is underpaying for TomoTherapy shares, thus unlawfully harming TomoTherapy stockholders. In particular, at least one analyst set a price target of $5.00 per share for TomoTherapy stock.

If you own common stock in TomoTherapy and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit [ http://www.zlk.com/tomotherapy-tomo.html ].

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.


Publication Contributing Sources